Literature DB >> 18439100

Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells.

Maryam Zamanian-Daryoush1, Joao T Marques, Michael P Gantier, Mark A Behlke, Matthias John, Patricia Rayman, James Finke, Bryan R G Williams.   

Abstract

Synthetic small interfering RNAs (siRNAs) can trigger a strong innate immune response in mammalian cells. This nonspecific side effect may hinder the application of siRNAs as tools in gene silencing. Chemically synthesized siRNAs, including traditional 19-mers with 2-nt 3' overhangs, longer duplexes with blunt or 3' overhangs, and asymmetric duplexes with a blunt end and a 2-nt 3' overhang, can evoke strong dose-dependent interferon-alpha (IFN-alpha) and tumor necrosis factor-alpha (TNF-alpha) release in human peripheral blood mononuclear cells (PBMCs). This response is independent of retinoic acid-inducible gene I but may involve endosomal toll-like receptors (TLRs). The immunostimulatory effect of the siRNAs is directly related to either or both of the strands of the duplex in a sequence-dependent manner. However, although some single-stranded RNAs and siRNAs potently evoked both IFN-alpha and TNF-alpha induction, these responses were not always coupled. In accordance with this, specific chemical modifications differentially altered cytokine production, suggesting recruitment of different TLRs in a sequence-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439100     DOI: 10.1089/jir.2007.0090

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  19 in total

1.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Authors:  Michael A Collingwood; Scott D Rose; Lingyan Huang; Chris Hillier; Mohammad Amarzguioui; Merete T Wiiger; Harris S Soifer; John J Rossi; Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-06

2.  A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery.

Authors:  David N Nguyen; Phillip Kim; Luis Martínez-Sobrido; Brett Beitzel; Adolfo García-Sastre; Robert Langer; Daniel G Anderson
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

3.  Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.

Authors:  S-T Chou; Q Leng; P Scaria; M Woodle; A J Mixson
Journal:  Cancer Gene Ther       Date:  2011-08-05       Impact factor: 5.987

4.  Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing.

Authors:  Hyejung Mok; Soo Hyeon Lee; Ji Won Park; Tae Gwan Park
Journal:  Nat Mater       Date:  2010-01-24       Impact factor: 43.841

5.  Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects).

Authors:  Cordula Weber; Christian Müller; Anja Podszuweit; Carmen Montino; Jörg Vollmer; Alexandra Forsbach
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

6.  Immune activation and target organ damage are consequences of hydrodynamic treatment but not delivery of naked siRNAs in mice.

Authors:  Zsuzsanna Rácz; Mária Godó; Csaba Révész; Péter Hamar
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

7.  Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.

Authors:  Worapol Ngamcherdtrakul; Jingga Morry; Shenda Gu; David J Castro; Shaun M Goodyear; Thanapon Sangvanich; Moataz M Reda; Richard Lee; Samuel A Mihelic; Brandon L Beckman; Zhi Hu; Joe W Gray; Wassana Yantasee
Journal:  Adv Funct Mater       Date:  2015-05-13       Impact factor: 18.808

8.  Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters.

Authors:  Jonathan K Watts; Dongbo Yu; Klaus Charisse; Christophe Montaillier; Pierre Potier; Muthiah Manoharan; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-04-19       Impact factor: 16.971

9.  RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.

Authors:  Rene Alvarez; Sayda Elbashir; Todd Borland; Ivanka Toudjarska; Philipp Hadwiger; Mathias John; Ingo Roehl; Svetlana Shulga Morskaya; Rick Martinello; Jeffrey Kahn; Mark Van Ranst; Ralph A Tripp; John P DeVincenzo; Rajendra Pandey; Martin Maier; Lubomir Nechev; Muthiah Manoharan; Victor Kotelianski; Rachel Meyers
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

10.  Drug delivery-mediated control of RNA immunostimulation.

Authors:  David N Nguyen; Steve C-Y Chen; James Lu; Michael Goldberg; Phillip Kim; Andrew Sprague; Tatiana Novobrantseva; Jennifer Sherman; Svetlana Shulga-Morskaya; Antonin de Fougerolles; Jianzhu Chen; Robert Langer; Daniel G Anderson
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.